| Literature DB >> 26620927 |
Elisa Biamino1, Eleonora Di Gregorio2, Elga Fabia Belligni1, Roberto Keller3, Evelise Riberi1, Marina Gandione4, Alessandro Calcia5, Cecilia Mancini5, Elisa Giorgio5, Simona Cavalieri2,5, Patrizia Pappi2, Flavia Talarico2, Antonio M Fea6, Silvia De Rubeis7,8, Margherita Cirillo Silengo1, Giovanni Battista Ferrero1, Alfredo Brusco2,5.
Abstract
Copy number variation (CNV) has been associated with a variety of neuropsychiatric disorders, including intellectual disability/developmental delay (ID/DD), autism spectrum disorder (ASD), and schizophrenia (SCZ). Often, individuals carrying the same pathogenic CNV display high clinical variability. By array-CGH analysis, we identified a novel familial 3q29 deletion (1.36 Mb), centromeric to the 3q29 deletion region, which manifests with variable expressivity. The deletion was identified in a 3-year-old girl diagnosed with ID/DD and autism and segregated in six family members, all affected by severe psychiatric disorders including schizophrenia, major depression, anxiety disorder, and personality disorder. All individuals carrying the deletion were overweight or obese, and anomalies compatible with optic atrophy were observed in three out of four cases examined. Amongst the 10 genes encompassed by the deletion, the haploinsufficiency of Optic Atrophy 1 (OPA1), associated with autosomal dominant optic atrophy, is likely responsible for the ophthalmological anomalies. We hypothesize that the haploinsufficiency of ATPase type 13A4 (ATP13A4) and/or Hairy/Enhancer of Split Drosophila homolog 1 (HES1) contribute to the neuropsychiatric phenotype, while HES1 deletion might underlie the overweight/obesity. In conclusion, we propose a novel contiguous gene syndrome due to a proximal 3q29 deletion variably associated with autism, ID/DD, psychiatric traits and overweight/obesity.Entities:
Keywords: autistic spectrum disorder; contiguous gene syndrome; intellectual disability; obesity; schizophrenia
Mesh:
Year: 2015 PMID: 26620927 DOI: 10.1002/ajmg.b.32406
Source DB: PubMed Journal: Am J Med Genet B Neuropsychiatr Genet ISSN: 1552-4841 Impact factor: 3.568